Setting Targets. Reaching Goals. Improving Lives.
The mission of Treat To Target is to provide clear direction on rheumatoid arthritis treatment target(s) and tight control, apply it in daily practice, and define a clinical state where irreversible joint damage and disability is avoided.
More About T2T
View T2T Principles
The treatment of rheumatoid arthritis must be based on a shared decision
between patient and rheumatologist.
- Patient must be informed on:
- Therapeutic options
- Reasons for recommending a particular therapeutic approach (benefit/risk)
- Patient should partake in the decision of which therapy should be applied
The primary goal of treating the patient with rheumatoid arthritis is to maximize long-term health-related quality of life (HR-QoL) through control of symptoms, prevention of structural damage, normalization of function, and social participation.
Abrogation of inflammation
is the most important way to achieve these goals.
- The inflammatory response underlying rheumatoid arthritis is responsible for the signs and symptoms of the disease and is associated with adverse outcomes in:
- long-term HR-QoL
- prevention of structural damage
- normalization of function
- social participation
Treatment to target by measuring disease activity and adjusting therapy accordingly optimizes outcomes in rheumatoid arthritis.
**This website is intended for Healthcare Professionals only.**